SLC17A7 and Alzheimer disease: The synaptic glutamate transporter vGLUT1 showed decreased levels in MCI subjects, but not in AD, compared to controls, whereas the synaptic GABA transporter GAT1 and the ratio vGLUT/GAT1 did not show differences (Supplementary Fig. 7c, Supplementary dataset 19, online resource).